Hot Safest Companies To Watch For 2015

Hot Safest Companies To Watch For 2015: Durect Corporation(DRRX)

DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical products and therapies based on its proprietary drug formulations and delivery platform technologies. The company sells ALZET osmotic pumps for animal research use; LACTEL biodegradable polymers, which are used as raw materials in pharmaceutical and medical products; and excipients for pharmaceutical and medical device clients for use as raw materials in their products. Its product pipeline consists of Remoxy, an oral oxycodone gelatin capsule for the treatment of chronic pain under approval stage with the U.S. Food and Drug Administration; POSIDUR, a Phase III clinical stage sustained-release formulation of bupivacaine for the treatment of post-surgical pain; ELADUR, a Phase II clinical stage transdermal bupivacaine patch intended to provide continuous delivery of bupivacaine for up to three days from a single application for pain; and TRANSDUR, a Phase II clinical stage transdermal sufentanil patch intended to provide continuous delivery of sufentanil for up to seven days from a single application for chronic pain. The company?s Phase II clinical stage products comprise ORADUR-based opioid for the treatment of pain; and ORADUR-ADHD for the treatment of attention deficit hyperactivity disorder. It also conducts various research programs covering diseases and medical conditions of the central nervous system, cardiovascular disease, and cancer. The company has strategic agreement with Hospira, Inc.; Alpharma Ireland Limited; Nycomed Danmark ApS; Pain Therapeutics, Inc.; Pfizer Inc; Endo Pharmaceuticals Inc.; and EpiCept Corporation. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California.

Advisors' Opinion:

• [By Roberto Pedone]

  One under-$10 name that's starting to move within range of triggering a major breakout trade is Durect (DRRX), which develops pharmaceutical products based on it! s proprietary drug delivery technology platforms. This stock is off to a hot start in 2013, with shares up sharply by 41%.

  If you take a look at the chart for Durect, you'll notice that this stock has been trending sideways for the last two months and change, with shares moving between $1 on the downside and $1.34 on the upside. Shares of DRRX have now started to flirt with that $1.34 major resistance level on Thursday, since the stock has hit an intraday high of $1.35 a share with strong upside volume flows. This could be signaling that shares of DRRX are ready to break out above the upper-end of its recent range and trend substantially higher.

  Traders should now look for long-biased trades in DRRX if it manages to break out above some near-term overhead resistance levels at $1.34 to $1.35 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 679,480 shares. If that breakout triggers soon, then DRRX will set up to re-fill some of its previous gap down zone from May that started near $1.80 a share. If DRRX gets into that gap with volume, then this stock could easily trend north of $2 a share.

  Traders can look to buy DRRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at its 50-day moving average of $1.16 a share or its 200-day moving average at $1.11 a share. One can also buy DRRX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-safest-companies-to-watch-for-2015.html